Sunday, February 4, 2024

Arthroscopy Instruments Market Size, Strategies & Key Players Review by Forecast to 2032

Arthroscopy Instruments Market Outlook

The Arthroscopy Instruments Market Size is expected to reach USD 6.42 Billion by 2032 at 6.2% CAGR during the forecast period 2023-2032.

Arthroscope is a trusted and well-developed form of surgery used by numerous surgeons and physicians throughout the world. This system has a camera, a fiber optic light, a small lens, and a monitor that is inserted into the patient's bones to inspect and treat the damaged region. This technique is usually used to treat injuries to the knee, back, elbows, knees, wrists, and ankles.

Key Players

Some of major the Arthroscopy Instruments Market Players include are

Conmed (U.S.),

Smith & Nephew (U.K.),

Medtronic, Inc. (U.S.),

Arthex (U.S.),

DePuy Synthes (U.S.),

Stryker (U.S.),

Zimmer Biomet (U.S.),

B. Braun (Germany),

Karl Storz (Germany),

Olympus (Japan),

Richard Wolf (Germany),

Medicon (Germany),

Sklar (U.S.),

GPC Medical (India),

Millennium (U.S.), and others.

Segmentation

The global Arthroscopy Instruments Market Research segmented on the basis of product, application, and end-user.

·         Based on the product, the market is divided into arthroscopes, arthroscopic implants, fluid management systems, visualization systems, radiofrequency systems, power shavers, and others. In addition, arthroscopic implants are segmented as knee implants, hip implants, shoulder implants, and others. Radiofrequency systems are further segmented as RF probes, RF generators, and wands and footswitches.

·         On the basis of application, the market for arthroscopy instrument is divided into knee arthroscopy, hip arthroscopy, foot and ankle arthroscopy, spine arthroscopy, shoulder arthroscopy, and others (wrist and hand arthroscopy).

·         On the basis of end-user, the market for arthroscopy instrument is segmented into hospitals, ambulatory surgical centres, and others.

Market Dynamics

A variety of factors, such as growing preference for minimally invasive procedures, increasing technological advancements, and improving the regulatory environment, are fuelling the growth of the global market for arthroscopy instruments. In addition, the rise in the incidence of sport-related musculoskeletal disorders, such as a bone tumor, rheumatoid arthritis, and osteoarthritis, is driving the development of this sector. The World Health Organization estimates that the prevalence of rheumatoid arthritis is between 0.3% to 1% and is more severe in women and developed countries. In addition, the projection also indicates that 9.6% of men and 18.0% of women over 60 years of age have osteoarthritis.

Despite these factors, the rising cost of arthroscopy instruments, the challenges of reimbursement in the medical device industry, and the weak healthcare system in low and middle-income countries may hinder the market growth. As stated in National Center for Health Statistics in the United States, nearly 650,000 arthroscopic lavage and debridement procedures are conducted annually for knee pain at an average cost of USD 5,000 each.

Regional Analysis

Geographically, the global Arthroscopy Instruments Market Report has been segmented into the Americas, Europe, the Asia Pacific, and the Middle East and Africa.

The Americas dominates the global market for arthroscopy instruments due to the presence of significant players in the industry, the high rate of adoption of minimally invasive devices and the rising incidence of joint-related diseases are boosting the market growth in this area. However, according to the American Orthopedic Society for Sports Medicine in the United States, an estimated 4 million individuals undergo knee arthroscopies, although the number of patients undergoing shoulder arthroscopies is 1.4 million each year. In addition, growing cases of arthroscopic surgery, along with rising health awareness, are driving the growth of the demand for arthroscopic instruments.

Europe is the second-largest arthroscopic instrument market in the world. Government support for research and development spending and increasing prevalence of bone disorders is expected to drive the European market. In fact, according to Arthritis Research U.K., around 10 million people had a form of arthritis in the U.K. in 2016. In addition, it has been projected that over 86,000 hip replacements and over 90,000 knee replacements take place every year.

The Asia Pacific is the fastest-growing region in the global market for instruments for arthroscopy due to a vast patient pool, rising demand for minimally invasive surgeries, and the advancement of healthcare technology. According to Osteoporosis Australia, about 4.74 million Australians over the age of 50 suffer from either poor bone health or osteoporosis, which further fuel the need for arthroscopy surgery. Healthcare spending has been increased in different regions of the Asia Pacific. Moreover, the availability of qualified physicians and nurse practitioners and the low cost of surgery have fuelled medical tourism in India. Most main players are expanding their business in emerging economies in the Asia Pacific region.

The Middle East & Africa has the lowest market share in the world due to low growth, lack of technical expertise, and weak medical facilities.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Opioid Withdrawal Treatment Market Players, Business Development, Share, Upcoming Trends by 2032

The global Opioid Withdrawal Treatments Market Size will rise to USD 3.16 billion by the end of the year 2032. The market valuation will grow at the CAGR rate of 10.1% over the upcoming period.  The global opioid withdrawal treatment market is mainly driven by the growing opioid epidemic in North America and Europe and the increasing awareness about various treatments that can be taken to reduce opioid withdrawal symptoms. The high alertness in the U.S. and Europe with regard to the overuse of prescribed opioid drugs is likely to remain a major driver for the opioid withdrawal treatment market over the forecast period. The growing healthcare industry and the growing prescription of opioid drugs in these regions is likely to remain a key driver for the opioid withdrawal treatment market over the forecast period.

Opioids are usually prescribed for pain management and have become a widely popular class of medications due to the absence of synthetic classes of drugs to perform the same task. Usually, the healthcare industry uses a natural compound as a platform for further variations and comes up with synthetic drug formulations. However, the industry has been unable to do that with regard to opioid drugs, as mimicking the analgesic effects of natural opioids has proved too difficult. This has driven prescription figures for opioids and is likely to remain a major driver for the opioid withdrawal treatment market over the forecast period.

Competitive Analysis:

Leading Opioid Withdrawal Treatments Market Players include

Bayer AG,

F. Hoffman-La Roche Ltd.,

Johnson & Johnson Services,

Sanofi,

Novartis,

Pfizer Inc.,

Teva Pharmaceutical Industries Ltd., and

Merck & Co.

Segmentation:

The global Opioid Withdrawal Treatments Market Insights has been segmented on the basis of drug type, distribution channel, and region.

·         By drug type, the opioid withdrawal treatment market has been segmented into nonsteroidal anti-inflammatory drugs, anti-nausea medications, analgesics, natural sleep supplements, and others.

·         On the basis of distribution channel, the market has been segmented into hospital pharmacy, retail pharmacies, and online stores.

Regional Analysis:

The Americas is likely to remain the leading regional Opioid Withdrawal Treatments Market Outlook over the forecast period due to the growing demand for opioid withdrawal treatments in the region. According to the CDC, two thirds of the deaths attributed to drug overdoses in the U.S. in 2016 involved an opioid. This is the major driver for the opioid withdrawal treatment market in North America, as the increasing awareness about the involvement of opioids in drug overdose cases is likely to be a major driver for the opioid withdrawal treatment market over the forecast period. Increasing awareness about NSAIDs and analgesics is likely to be a major driver for the Americas market for opioid withdrawal treatment market in the Americas over the forecast period.

Increasing development of other pain management medications in North America is also likely to be a major driver for the opioid withdrawal treatment market in North America over the forecast period. The major growth driver for the opioid withdrawal treatment market has been the absence of other classes of pain medications to deal with the pain problem without using opioids. Mankind’s dependence on opioids has thus resulted in a growing demand for the development of other pain medication classes, which can deliver comparable relief without using opiates. North America is likely to be a major center for the development of these drugs in the coming years, leading to a growing demand from the opioid withdrawal treatment market over the forecast period.

Europe accounts for the second largest market for opioid withdrawal treatments and is likely to retain a considerable share in the global opioid withdrawal treatment market over the forecast period.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Amyotrophic Lateral Sclerosis Market Size By Application, By End Use, And Segment Forecasts 2022 - 2030

Market Analysis

The amyotrophic lateral sclerosis market Size was valued at USD 0.75 billion in 2022. The Amyotrophic Lateral Sclerosis market industry is projected to grow from USD 0.79 Billion in 2023 to USD 1.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.10% during the forecast period (2023 - 2030).

ALS or Amyotrophic Lateral Sclerosis is a neurological ailment which affects the nerve cells in the spinal cord and the brain that controls the voluntary muscles’ activities. Some of the common symptoms of ALS include cramps, muscle weakness, respiratory problems, and fasciculation. This is a progressive neurological disease where gradually patients become dependent on physicians and caregivers increasingly. Often ALS results in respiratory failure as the patient loses the ability of

There are many factors that are driving the growth of the amyotrophic lateral sclerosis market. Some of these factors as per the Market Research Future (MRFR) report include rising incidences of ALS, increase in awareness among patients, increase in geriatric population, FDA approvals and initiatives taken by the government on R&D activities. On the other hand, factors such as low treatment availability and high treatment cost may hinder the growth of the amyotrophic lateral sclerosis market.

Key Players

The amyotrophic lateral sclerosis market players include

·         Sun Pharmaceutical (India),

·         Sanofi (France),

·         Mylan N.V. (USA),

·         Mitsubishi Tanabe Pharma America (USA),

·         ITF Pharma (USA),

·         Ionis Pharmaceutical (USA),

·         Covis Pharma (Switzerland),

·         Biogen (USA),

·         Ascend Pharmaceuticals LLC (USA) and

·         Apotex Inc. (Canada).

Market Segmentation

As per the MRFR report, the amyotrophic lateral sclerosis market is segmented into type, treatment, and end user.

·         Based on type, it is segmented into sporadic ALS and familial ALS. Of these, the sporadic ALS segment will dominate the market during the forecast period.

·         Based on treatment, the amyotrophic lateral sclerosis market is segmented into speech therapy, respiratory therapy, physical therapy, medication, and others.

·         Based on end-users, it is segmented into specialty centers, research and academic institutes, hospitals and others. Of these, the hospital segment will have the highest growth during the forecast period.

Regional Analysis

Based on region, the amyotrophic lateral sclerosis market covers growth opportunities and latest trends across North America, Europe, Asia Pacific, and the Middle East and Africa. Of these, North America will lead the market during the forecast period owing to support from the government for R&D, rising pool of awareness, the existence of many leading market players, increasing incidence of hypertension, and advanced medical facilities. Canada and the USA are the largest contributors in this region. Europe will have the second largest share in the amyotrophic lateral sclerosis market during the forecast period. The UK, Germany, and France will be the largest contributors in this region. In the APAC region, the amyotrophic lateral sclerosis market is anticipated to grow rapidly owing to the rapidly expanding healthcare infrastructure, increasing the incidence of ALS, the presence of the growing economies mainly India and China, and increasing setups of R&D centers. South Korea, Japan, and Australia are the other vital country-specific markets here. On the other hand, the amyotrophic lateral sclerosis market in the Middle East and Africa will have the smallest share owing to poor countries, inadequate healthcare facilities, lack of education, medical facilities having low standard, lack of awareness and lack of advanced and innovative medical facilities.

Feb 2019- Leading technology transfer company, BGN Technologies has lately disclosed about a new AI (artificial intelligence) platform to monitor and predict the development of neurodegenerative diseases in order to identify markers both for improved drug development and personalized patient care. This technology will focus on ALS at an initial stage and later on will be adapted to other neurodegenerative diseases namely Alzheimer’s and Parkinson’s. The latest technology will predict disease progression more accurately, a key component for clinical trials along with better identifying the interrelationships amid demographics and many other measurable factors that are identified through patient functionality and physical examinations. It will allow researchers in creating a system which insurers, HMOs, pharmaceutical companies, caregivers, physicians, and patients can use on mobile applications and desktop for monitoring and predicting ALS progression.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Friday, February 2, 2024

Americas Cancer Immunotherapy Market Share, Insights and Forecast to 2030

Market Highlights

The Americas Cancer Immunotherapy Market Share is expected to grow at USD 118274.96 Million by 2030 at an approximate CAGR of 13.80% during the forecast period 2022-2030. 

Cancer Immunotherapy is an advanced paradigm in cancer therapeutics. Cancer immunotherapy works by enhancing the patient’s immune system. This is generally accompanied by the administration of synthesized immune proteins. The most common therapeutic areas of cancer immunotherapy are inclusive of breast, prostate, lung cancer, and others. Increasing prevalence of the cancer is one of the major drivers for the market growth during the forecast period. Moreover, growing geriatric population and rising healthcare expenditure, increasing biotech and pharmaceutical sector boosts the market growth. However, lack of awareness and high cost for the services may restrain the market growth. 

Key Players

Some of the major Americas Cancer Immunotherapy Market Players in the market are

Amgen Inc. (U.S.),

 AstraZeneca (U.K),

F. Hoffmann-La Roche Ltd. (Switzerland),

Bayer AG (Germany),

Bristol-Myers Squibb Company (U.S.),

Eli Lilly and Company (U.S.),

Merck & Co., Inc. (U.S.),

Pfizer Inc. (U.S.),

Novartis AG (Switzerland), and others.

Segmentation

The Americas cancer immunotherapy market outlook is segmented on the basis of cancer, therapeutics, and end users.

·         On the basis of the cancer, the market is segmented into lung cancer, prostate cancer, colorectal cancer, head & neck cancer, and others.

·         On the basis of the therapeutics, the market is segmented into monoclonal antibodies, immune checkpoint inhibitors, vaccines, non-specific cancer immunotherapies and adjuvants, and others.

·         On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, research organization, and others.

Regional Analysis

On regional basis the Americas is divided into North America and Latin America. North America is sub segmented into U.S. and Canada. North America commands for the largest market. The large share is also attributed due to the technologically advanced healthcare market, high prevalence of cancer, increasing development in cancer immunotherapy treatment and rising per capita healthcare expenditure. According to the National Cancer Institute in 2016, an estimated 1,685,210 new cases of cancer were diagnosed in the U.S. and approximately 595,690 people died due to cancer within the region. This is projected to drive the healthcare expenditure for cancer. By 2020, approximately USD 156 billion will invested on the cancer therapeutics and diagnostics.

On the other hand, Latin America is the fastest growing region due to the presence of the developing economies within the region, rising healthcare expenditure along with the huge patient population. Moreover, the presence of huge opportunities within the region fuels the market growth during the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Body Contouring Market Outlook Overview, Trends,Share and Forecast by 2032

Market Analysis

The global body contouring market research share is predicted to grow at a 14.0% CAGR over the forecast period (2023-2032), as per the latest Market Research Future (MRFR) report. Body contouring, which is also known as body sculpting, is a surgical procedure which improves the appearance of tissue and skin after a considerable weight loss. This procedure can include liposuction, breast lift, tummy tuck, or body lift. An average body contouring session will last about an hour but has no downtime. It has gained immense popularity as people are looking for safer, cost-effective, and less painful alternatives for getting the desired body shape.

Body contouring can be done both surgically and non-surgically, and both are gaining ample recognition. Although this procedure can address any part of the body but some of the most common areas which people seek to improve include calves, thighs, waistline and back, abdomen, breasts, upper arms, and face and neck.

Various factors are propelling in the body contouring market. These factors, as stated by the MRFR report, include increasing obese population, lack of exercise, diseases such as diabetes and cardiovascular ailments, adoption of fast food, and rising awareness and accessibility of cosmetic surgeries. Additional factors boosting market growth include advancements in technology, rising disposable income, demand for improved fat reduction procedures, presence of sophisticated infrastructure, expanding medical tourism industry, and growing urbanization. Besides, the different benefits that body contouring offers such as faster recovery time, minimal invasion, accurate fat measurement and removal, less trauma, and targeted internal delivery are also boosting the market growth.

On the contrary, the high cost of therapy may hinder the body contouring market trends growth over the forecast period.

 Key Players

the body contouring market players report include Wells Johnson Company (US), Erchonia (US), Invasix Aesthetic Solutions (US), InMode (US), Human Med (Germany), Chromogenex (UK), GlobalMed Technologies (US), Fotona (Slovenia), Cutera (US), BTL Industries (US), Andrew Technologies (Canada), Asclepion Laser Technologies (Germany), Valeant (Canada), Palomar Medical Technologies (US), Lumenis (Israel), Syneron Medical (Israel), Cynosure (US), Meridian (Michigan), and Alma Lasers (Israel).

July 2019: A new body-contouring device, CoolTone has received FDA clearance to firm up muscles in the thigs, butt, and the abs.

Market Segmentation

The Market Research Future report provides a wide segmental analysis of the body contouring market based on type.

Based on type, the body contouring marke is segmented into non-invasive and minimally invasive devices. The non-invasive devices segment is again segmented into high intensity focused ultrasound lipoplasty devices and radio frequency lipoplasty devices. The minimally invasive devices segment is again segmented into radio frequency assisted liposuction devices and laser-assisted lipolysis devices. Of these, the non-invasive segment will have the largest share in the market over the forecast period. This is owing to heavy investments being made by leading companies for developing advanced equipment and technologies. Moreover, its alluring features such as cost-effectiveness, short downtimes, and enhanced safety are also boosting the market growth.

Regional Analysis

Based on the region, the body contouring market report covers growth opportunities and the latest trends across the Asia Pacific (APAC), Europe, North America, and the Middle East and Africa (MEA). Of these, North America will spearhead the market over the forecast period. This is owing to 55% of the population in this region is suffering from obesity. Besides, governmental support for R&D activities for various surgery and devices and rising healthcare expenditure are also pushing market growth.

The body contouring market in Europe is predicted to have the second-largest share in the market over the forecast period.

The body contouring market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to increasing consumer disposable income, the presence of a huge target population, and the introduction of advanced products. Moreover, the growing demand for better devices and treatment and the rising prevalence of obesity and diabetes are pushing market growth. India, South Korea, Japan, and China are the key contributors in this region.

The body contouring market in the Middle East and Africa is predicted to have steady growth over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Fluoroscopy and Mobile C-Arms Market Outlook: Global Industry Share, Growth, Drivers, Emerging Technologies, and Forecast 

Market Overview

Fluoroscopy can be defined as an imaging technique, which uses X-Ray technology for taking real-time images of the body. It allows the physicians to visualize muscles, organs, and bones, which further helps them to make crucial decisions during surgery. Fluoroscopy and Mobile C-Arms Market ShareSize is anticipated to reach USD 4.32 Billion by 2032 at 4.7% CAGR during the forecast period 2023-2032.

Factors like the rising incidence of chronic diseases, ever-increasing geriatric population, and high adoption of fluoroscopy in neurological and orthopedic procedures will supplement the market growth in the segment. Improving healthcare infrastructure, advancing technology in fluoroscopy and C-arms equipment, and increasing number of interventional radiology surgeries are likely to elevate the scope for the market across the globe. Moreover, rapid product launches and rising number of mergers and acquisitions will further contribute to the market growth in the long run. The shift towards a value-based healthcare model, surging adoption of minimally invasive surgeries, and soaring demand for improved imaging technology are likely to promote the market growth in the coming years.

On the contrary, the high cost of fluoroscopic and mobile c-arm systems, coupled with the risk of radiation exposure are some of the key concerns likely to restrict the market growth across the globe.

Fluoroscopy and Mobile C-Arms Market Outlook and Report Analysis By Device Type (Fluoroscopy Systems & Mobile C-Arms), Application (Gastrointestinal, Orthopedics, Neurology, & Others), End User (Hospital & Clinics & Others), Region - Forecast till 2030

 

Competitive Dashboard

The top operating in the Fluoroscopy and Mobile C-Arms Market Players scope include Canon Medical Systems Corporation (Japan), Allengers Medical Systems (India), GE Healthcare (US), DMS Group (France), Hologic Inc. (US), Hitachi Ltd (Tokyo), OrthoScan, Inc. (the US), Omega Medical Imaging, LLC (US), Shimadzu Corporation (Japan), Koninklijke Philips N.V. (The Netherlands), Varian Medical Systems, Inc. (US), Siemens (Germany), Ziehm Imaging GmbH (US), and Villa Sistemi Medicali Spa (Italy).

Global Fluoroscopy and Mobile C-Arms Market: Segmental Analysis

The Fluoroscopy and Mobile C-Arms Market analysis has been segmented on the basis of application, device type, and end user.

·         By device type, the market is segmented into fluoroscopy systems and mobile c-arms. Of these, the mobile C-arms segment will gain significant prominence, mainly due to the soaring incidence of cardiovascular disease and the rising number of orthopedic surgeries. C-arms are extensively used for surgeries of cardiovascular diseases, gastroenterology, neurosurgeries, traumatology, orthopedics, and urology disorders.

·         The market finds application in orthopedics, gastrointestinal, cardiovascular, pain management and trauma, urology, neurology, and others. Of these, the cardiovascular application will gain prominence due to the increased burden of cardiovascular diseases and better results offered by fluoroscopy systems during treatment and diagnosis.

·         Based on the end users, the market constitutes diagnostic centers, hospital and clinics, research and academic institutes, and others. Of these, the hospital and clinics segment accounted for USD 895.96 million in 2017. The high adoption of advanced and sophisticated imaging systems will drive the market growth in the segment.

Regional Frontiers

Geographically, the Fluoroscopy and Mobile C-Arms Market Outlook have been studied under regions namely, Europe, the Americas, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, the Americas is predicted to acquire the lion’s share and dominate the market globally. In this region, North America is predicted to command the largest share, mainly due to the acceptance of innovative and latest products. Also, the surging awareness regarding medical imaging devices and rising financial capability to purchase expensive machines are driving the market growth in the region.

Europe is likely to register moderate growth in the foreseeable future. The regional growth can be credited to the surging prevalence of road accidents, which leads to orthopedic surgeries. The rising expenditure in the healthcare sector and increasing R&D activities will further contribute to the market growth in the long run.

Meanwhile, the Asia Pacific will register the fastest growth across the globe. Developing countries like India, China, and South Korea are gradually becoming major destinations for pathology testing and outsourcing clinical trials. This is likely to elevate the scope of the market in the region. The presence of untapped opportunities, surging awareness about medical imaging techniques and applications, and improving healthcare infrastructure are encouraging the regional market’s growth.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Syringe and Needle Market Size : A Global Analysis of the Market Trends

Market Overview-

The global syringe and needle market size is expected to grow USD 14.74 billion by 2032 at a CAGR of 5.90% and surpass its previous revenues over the forecast period of 2023–2032, as per a research report published by Market Research Future (MRFR). The syringe and needle market is growing primarily on account of a large pool of patients who augment the demand for needle and syringe. High prevalence of blood-borne diseases leads to a surge in the application of syringes and needles which fuels the market growth. The global geriatric population is increasing and contributing significantly to the market growth. This demographic is at high risk for chronic diseases, and the natural aging process weakens the body leading to increased overall medical visits. Increased demand for hypodermic needles which prevent the risk of needle-stick injuries also aids the growth of the market. Implementation of vaccination programs for diseases such as hepatitis, polio, rubella, tetanus, etc., also induces demand for needles and syringes which help in market expansion. Increase in a number of injectable drugs approved by the FDA also propels the market for syringes and needles. However, the growth of the market might be hindered by the risk associated with re-use and sharing of needles and syringes. Reuse of needles exposes consumers to the risk of acquiring diseases such as HIV and hepatitis C which is a major setback and constrain to the market growth. Risk of needlestick injuries and availability of alternatives also hinders the growth of the market. The market growth might be threatened by the introduction of needleless alternatives to meet the demands of a minimally invasive medical procedures.

Competitive Landscape

Global Syringe and Needle Market Players include

  • Braun Medical Inc.,
  • Terumo Corporation,
  • Albert David Ltd,
  • Covidien Plc,
  • Smiths Medical, and
  • Connecticut Hypodermics Inc.

Segmentation

The global syringes and needle market insights has been segmented based on type, therapeutic application, usability, and end-user. By type, the market has been segmented into Blood Collection, Intravenous, and Catheter. By therapeutic application, the market has been segmented into General Surgery and Diagnostic. By usability, the market has been segmented into disposable and reusable. By end user, the market has been segmented into Hospitals & Clinics and Home Care.

Regional Analysis

The key markets of the global syringes and needle market include North America, Europe, Asia Pacific and the Middle East & Africa. North America accounts for the majority share of the global market owing to the prevalence of chronic diseases in the region coupled with increased R&D activities which induce the demand of the market. Additionally, the presence of a large customer base in the region also propels the market growth. Europe is the second largest market owing to increased R&D spending by pharmaceuticals and biotechnology sector in the region. Presence of a developed healthcare sector also supports the market growth in the region. Asia Pacific is expected to be the fastest growing market over the forecast period. The growth in the region would be favored by the prevalence of chronic diseases in the region which escalates the need for treatment and growing research and development in the field of life sciences in the region.  The Middle East & Africa region is expected to exhibit the least growth over the forecast period due to less expenditure on healthcare and limited growth of the healthcare sector in the region.

Industry Updates

An American pharmacy, Sunrise Pharmacy is reportedly accepting discarded needles found in public spaces for a reward of 5 cents per used needle. The move is an attempt to solve the issue of discarded drug paraphernalia. 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Growing Adoption of Non-Invasive Tattoo Removal Techniques: Market Implications

Tattoo Removal Market: Overview and Trends The tattoo removal market is a dynamic and growing sector within the global aesthetics industry...